Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research of Exenatide for Management of Reproductive and Metabolic Dysfunction in Overweight/Obese PCOS Patients With Impaired Glucose Regulation

NCT03352869 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT03352869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03352869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research of Exenatide for Management of Reproductive and Metabolic Dysfunction in Overweight/Obese PCOS Patients With Impaired Glucose Regulation
Lead sponsor
RenJi Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 28, 2017
Completion date
July 31, 2018
Enrollment
183 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorder of glucose regulation, overweight and obesity, polycystic ovary syndrome